FOLH1 and benign prostatic hyperplasia: PSMA expression is not exclusive to malignancy; benign conditions such as benign prostatic hyperplasia (BPH) and low-grade tumors may also exhibit PSMA uptake, potentially leading to false-positive interpretations.